SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 142 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 11.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $61,457 | -32.1% | 48,391 | +16.5% | 0.00% | 0.0% |
Q3 2021 | $90,531 | -21.0% | 41,528 | +35.8% | 0.00% | -50.0% |
Q2 2021 | $114,664 | -8.5% | 30,577 | -20.5% | 0.00% | 0.0% |
Q1 2021 | $125,363 | -13.3% | 38,455 | -9.3% | 0.00% | 0.0% |
Q4 2020 | $144,557 | -17.1% | 42,392 | -0.8% | 0.00% | -33.3% |
Q3 2020 | $174,400 | +35.9% | 42,745 | +12.6% | 0.00% | +50.0% |
Q2 2020 | $128,335 | +44.4% | 37,969 | -0.4% | 0.00% | 0.0% |
Q1 2020 | $88,845 | -32.0% | 38,131 | +6.2% | 0.00% | 0.0% |
Q4 2019 | $130,720 | -58.1% | 35,912 | -4.4% | 0.00% | -60.0% |
Q3 2019 | $311,668 | +8.1% | 37,573 | +12.2% | 0.01% | 0.0% |
Q2 2019 | $288,211 | -16.7% | 33,474 | +3.4% | 0.01% | -16.7% |
Q1 2019 | $346,025 | +22.2% | 32,369 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $283,229 | -47.9% | 32,369 | 0.0% | 0.01% | -40.0% |
Q3 2018 | $543,799 | -99.9% | 32,369 | 0.0% | 0.01% | -9.1% |
Q2 2018 | $678,454,000 | +49.6% | 32,369 | +14.8% | 0.01% | +83.3% |
Q1 2018 | $453,545,000 | +86952.8% | 28,188 | +2.5% | 0.01% | -14.3% |
Q4 2017 | $521,000 | -36.6% | 27,512 | -52.9% | 0.01% | +40.0% |
Q3 2017 | $822,000 | +87.7% | 58,400 | -0.7% | 0.01% | +66.7% |
Q2 2017 | $438,000 | +14.7% | 58,831 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $382,000 | +60.5% | 58,831 | +9.5% | 0.00% | +50.0% |
Q4 2016 | $238,000 | -14.1% | 53,720 | -9.4% | 0.00% | 0.0% |
Q3 2016 | $277,000 | -16.3% | 59,287 | +17.7% | 0.00% | 0.0% |
Q2 2016 | $331,000 | +11.8% | 50,358 | +8.2% | 0.00% | 0.0% |
Q1 2016 | $296,000 | +5.3% | 46,555 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $281,000 | +1.1% | 46,555 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $278,000 | -9.2% | 46,555 | +4.0% | 0.00% | 0.0% |
Q2 2015 | $306,000 | +2.7% | 44,768 | -8.8% | 0.00% | 0.0% |
Q1 2015 | $298,000 | -12.6% | 49,090 | -0.1% | 0.00% | 0.0% |
Q4 2014 | $341,000 | -14.8% | 49,135 | 0.0% | 0.00% | -33.3% |
Q3 2014 | $400,000 | +0.3% | 49,135 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $399,000 | +3.6% | 49,135 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $385,000 | -11.5% | 49,135 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $435,000 | +5.6% | 49,135 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $412,000 | +12.3% | 49,135 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $367,000 | – | 49,135 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,383,466 | $139,917,000 | 12.64% |
ASHFORD CAPITAL MANAGEMENT INC | 362,615 | $6,872,000 | 1.07% |
NEXTHERA CAPITAL LP | 259,300 | $4,914,000 | 0.91% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 639,856 | $12,125,000 | 0.89% |
Sonora Investment Management, LLC | 249,502 | $4,728,063,000 | 0.76% |
Kazazian Asset Management, LLC | 32,526 | $616,000 | 0.63% |
Piermont Capital Management Inc. | 88,372 | $1,675,000 | 0.55% |
J. Goldman & Co LP | 266,479 | $5,050,000 | 0.26% |
J. Goldman & Co LP | 251,500 | $4,766,000 | 0.25% |
Opaleye Management Inc. | 31,000 | $587,000 | 0.19% |